Boston Therapeutics, Inc. — Form D

Boston Therapeutics, Inc. of LAWRENCE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-07-05. The offering totals $508K, of which $508K was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
David PlattDirectorAtglen, PA
Kenneth A Tassey, Jr.DirectorManchester, NH
David PlattExecutive OfficerAtglen, PA
Kenneth A Tassey, Jr.Executive OfficerManchester, NH
Conroy Chi-Heng ChengDirectorLawrence, MA
David LudvigsonDirectorLawrence, MA
David LudvigsonExecutive OfficerLawrence, MA
Dale H ConawayDirectorNewton, MA
Colin W NeillDirectorLawrence, MA
Carl W RauschExecutive OfficerLawrence, MA
Alan W HobermanDirectorLawrence, MA
Rom W EliazDirectorLawrence, MA
Henry W EsberDirectorManchester, NH
Dale W ConwayDirectorManchester, NH
Rom H EliazDirectorManchester, NH
Carl H LuedersDirectorManchester, NH
Henry H EsberDirectorManchester, NH
Kenneth Tassey, Jr.DirectorManchester, NH
Kenneth Tassey, Jr.Executive OfficerManchester, NH
Kenneth Tassey, Jr.PromoterManchester, NH
David Platt, Ph. D.DirectorManchester, NH
David Platt, Ph. D.Executive OfficerManchester, NH
David Platt, Ph. D.PromoterManchester, NH

Other filings by this issuer (4)

FiledFormOfferingSold
2021-07-09D$8.4M$8.4M
2016-09-20D/A$2.0M$1.6M
2016-08-25D$2.0M$1.3M
2013-08-07D$8.0M$2.0M

More